{"id":3596,"date":"2022-03-10T15:55:25","date_gmt":"2022-03-10T14:55:25","guid":{"rendered":"https:\/\/hemerapharma.com\/presentazione-ricerca-sulla-stampa\/"},"modified":"2023-06-19T12:03:23","modified_gmt":"2023-06-19T10:03:23","slug":"press-research-presentation","status":"publish","type":"post","link":"https:\/\/hemerapharma.com\/en\/press-research-presentation\/","title":{"rendered":"The press speaks about Hemera after the press conference held in Verona"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row custom_padding_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; background_enable_color=&#8221;off&#8221; custom_padding=&#8221;3%|3%|3%|3%|true|true&#8221; custom_padding_tablet=&#8221;5%|5%|5%|5%|true|true&#8221; custom_padding_phone=&#8221;5%|5%|5%|5%|true|true&#8221; border_width_all=&#8221;17px&#8221; border_color_all=&#8221;#fdc82f&#8221; border_width_all_tablet=&#8221;14px&#8221; border_width_all_phone=&#8221;8px&#8221; border_width_all_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_post_title author=&#8221;off&#8221; comments=&#8221;off&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; title_font=&#8221;|600|||||||&#8221; title_font_size=&#8221;36px&#8221; title_line_height=&#8221;1.4em&#8221; meta_font=&#8221;|700|||||||&#8221; meta_text_color=&#8221;#fdc82f&#8221; background_enable_color=&#8221;off&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||3%||false|true&#8221; border_width_bottom=&#8221;1px&#8221; border_color_bottom=&#8221;#bababa&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_post_title][et_pb_text _builder_version=&#8221;4.19.5&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|700|||||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#fdc82f&#8221; header_font_size=&#8221;26px&#8221; header_line_height=&#8221;1.2em&#8221; header_2_font=&#8221;|600|||||||&#8221; header_2_font_size=&#8221;36px&#8221; header_2_line_height=&#8221;1.4em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#fdc82f&#8221; header_3_font_size=&#8221;26px&#8221; header_3_line_height=&#8221;1.4em&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_font_size=&#8221;20px&#8221; header_4_line_height=&#8221;1.4em&#8221; header_5_font=&#8221;|700|||||||&#8221; header_5_font_size=&#8221;18px&#8221; header_5_line_height=&#8221;1.4em&#8221; header_6_font_size=&#8221;16px&#8221; header_6_line_height=&#8221;1.4em&#8221; header_font_size_tablet=&#8221;30px&#8221; header_font_size_phone=&#8221;26px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; header_2_font_size_tablet=&#8221;36px&#8221; header_2_font_size_phone=&#8221;36px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>After the <strong>Press Conference held on Wednesday March 9, 2022 in Verona,<\/strong> the traditional and online press report the news of the presentation of Hemera&#8217;s \u2013 in collaboration with <strong>the University of Verona, the University of Milan, and the Humanitas Clinical Institute<\/strong> \u2013 all-Italian research for a new cell therapy promoting the regeneration of nervous tissue following spinal cord injury.<\/p>\n<p>Here is a first list of releases:<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; link_text_color=&#8221;#fdc82f&#8221; header_font=&#8221;|700|||||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#fdc82f&#8221; header_font_size=&#8221;26px&#8221; header_line_height=&#8221;1.2em&#8221; header_2_font=&#8221;|600|||||||&#8221; header_2_font_size=&#8221;36px&#8221; header_2_line_height=&#8221;1.4em&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#fdc82f&#8221; header_3_font_size=&#8221;26px&#8221; header_3_line_height=&#8221;1.4em&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#fdc82f&#8221; header_4_font_size=&#8221;20px&#8221; header_4_line_height=&#8221;1.4em&#8221; header_5_font=&#8221;|700|||||||&#8221; header_5_font_size=&#8221;18px&#8221; header_5_line_height=&#8221;1.4em&#8221; header_6_font_size=&#8221;16px&#8221; header_6_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;2%||2%||true|false&#8221; hover_enabled=&#8221;0&#8243; header_font_size_tablet=&#8221;30px&#8221; header_font_size_phone=&#8221;26px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; header_2_font_size_tablet=&#8221;36px&#8221; header_2_font_size_phone=&#8221;36px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#bababa&#8221; border_width_bottom=&#8221;1px&#8221; border_color_bottom=&#8221;#bababa&#8221; global_colors_info=&#8221;{}&#8221; header_2_text_color__hover_enabled=&#8221;on|desktop&#8221; header_2_text_color__hover=&#8221;#fdc82f&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_Univrmagazine.pdf\" target=\"_blank\" rel=\"noopener\">A reprogrammed cell paves the way for motor recovery for those with spinal lesions<\/a><\/h4>\n<p><strong>Univr Magazine<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_LArena-1.pdf\" target=\"_blank\" rel=\"noopener\">From Verona cells &#8220;trained&#8221; to repair spinal lesions<\/a><\/h4>\n<p><strong>L&#8217;Arena<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_La-Statale-News.pdf\" target=\"_blank\" rel=\"noopener\">Hemera: Univerona, Milan State University and Humanitas together for a regenerative medicine project<\/a><\/h4>\n<p><strong>La Statale News<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_Regione-Veneto-veneto.pdf\" target=\"_blank\" rel=\"noopener\">Healthcare. University of Verona protagonist of the &#8220;Hemera&#8221; regenerative medicine project. Zaia, &#8220;extraordinary strike against spinal lesions&#8221;<\/a><\/h4>\n<p><strong>Regione del Veneto<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_VenetoEconomia.pdf\" target=\"_blank\" rel=\"noopener\">Regenerative medicine, the all-Italian project for a therapy to repair spinal lesions<\/a><\/h4>\n<p><strong>Veneto Economia<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale__-Gazzettino.png.pdf\" target=\"_blank\" rel=\"noopener\">Spinal cord injuries, hope in the reprogrammed cell<\/a><\/h4>\n<p><strong>Il Gazzettino<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale__-GazzettinoSalute.pdf\" target=\"_blank\" rel=\"noopener\">A drug for spinal lesions<\/a><\/h4>\n<p><strong>Il Gazzettino Salute<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_Gruppo-Gedi.pdf\" target=\"_blank\" rel=\"noopener\">Spinal lesions, regenerative therapy is being tested<\/a><\/h4>\n<p><strong>La Nuova Venezia &#8211; La Tribuna di Treviso<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_Insalutenews.it_.pdf\">Spinal lesions, a reprogrammed cell promotes motor recovery. Made in Italy regenerative medicine project<\/a><\/h4>\n<p><strong>In Salute News<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_Italiasalute.pdf\" target=\"_blank\" rel=\"noopener\">A cell reprogrammed for spinal lesions<\/a>.<\/h4>\n<p><strong>ItaliaSalute.it<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_ClicMedicina.pdf\" target=\"_blank\" rel=\"noopener\">Reprogrammed cell opens new perspectives for motor recovery in spinal lesions. Italian research<\/a><\/h4>\n<p><strong>ClicMedicina<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_VenetoSociale.pdf\" target=\"_blank\" rel=\"noopener\">University of Verona: how to restore motor skills to people with spinal lesions<\/a><\/h4>\n<p><strong>Veneto Sociale<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_LArena.it_.pdf\" target=\"_blank\" rel=\"noopener\">Spinal lesions, the spin-off<\/a><\/h4>\n<p><strong>L&#8217;Arena.it<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_ScienzaOnline.pdf\" target=\"_blank\" rel=\"noopener\">Reprogrammed cell paves the way for motor recovery for those with spinal lesions<\/a><\/h4>\n<p><strong>ScienzaOnline<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_VeronSera.pdf\" target=\"_blank\" rel=\"noopener\">Spinal lesions, a reprogrammed cell paves the way for motor recovery<\/a><\/h4>\n<p><strong>Verona Sera<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_Primoweb.it_.pdf\" target=\"_blank\" rel=\"noopener\">Medicine, a drug against spinal cord lesions from the Universities of Verona and Milan<\/a><\/h4>\n<p><strong>PrimoWeb<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_Ladiscussione.pdf\" target=\"_blank\" rel=\"noopener\">Spinal lesions: a reprogrammed cell is being tested in Verona<\/a><\/h4>\n<p><strong>La Discussione.it<\/strong><\/p>\n<h4><a href=\"https:\/\/hemerapharma.com\/wp-content\/uploads\/2023\/06\/Rassegna-stampa-CS-VR-Hemera_ricerca-lesione-spinale_Ilserenissimoveneto.pdf\" target=\"_blank\" rel=\"noopener\">Spinal injuries, &#8220;Hemera&#8221; Project: the University of Verona wants to create a therapy to repair spinal lesions<\/a><\/h4>\n<p><strong>Il Serenissimo<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><em>Updated to March 28, 2022<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_gallery gallery_ids=&#8221;3125,3126,3127,3128&#8243; dbdb_version=&#8221;4.2.4&#8243; show_title_and_caption=&#8221;off&#8221; zoom_icon_color=&#8221;#fdc82f&#8221; hover_overlay_color=&#8221;rgba(0,0,0,0.57)&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_gallery][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>After the Press Conference held on Wednesday March 9, 2022 in Verona, the traditional and online press report the news of the presentation of Hemera&#8217;s \u2013 in collaboration with the University of Verona, the University of Milan, and the Humanitas Clinical Institute \u2013 all-Italian research for a new cell therapy promoting the regeneration of nervous [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[34],"tags":[],"class_list":["post-3596","post","type-post","status-publish","format-standard","hentry","category-press-review"],"acf":[],"_links":{"self":[{"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/posts\/3596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/comments?post=3596"}],"version-history":[{"count":27,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/posts\/3596\/revisions"}],"predecessor-version":[{"id":4511,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/posts\/3596\/revisions\/4511"}],"wp:attachment":[{"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/media?parent=3596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/categories?post=3596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hemerapharma.com\/en\/wp-json\/wp\/v2\/tags?post=3596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}